Cargando…

Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report

KEY CLINICAL MESSAGE: In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. ABSTRACT: BBIBP‐CorV COVID‐19 v...

Descripción completa

Detalles Bibliográficos
Autores principales: Riazi, Ali, Faghih Dinevari, Masood, Abbasian, Samaneh, Jabbaripour Sarmadian, Amirreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264932/
https://www.ncbi.nlm.nih.gov/pubmed/37323251
http://dx.doi.org/10.1002/ccr3.7535
_version_ 1785058429634609152
author Riazi, Ali
Faghih Dinevari, Masood
Abbasian, Samaneh
Jabbaripour Sarmadian, Amirreza
author_facet Riazi, Ali
Faghih Dinevari, Masood
Abbasian, Samaneh
Jabbaripour Sarmadian, Amirreza
author_sort Riazi, Ali
collection PubMed
description KEY CLINICAL MESSAGE: In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. ABSTRACT: BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine) is an inactivated whole virus vaccine to control the COVID‐19 pandemic. Studies concluded that inactivated COVID‐19 vaccines do not increase the risk of thrombosis. This report presents a 23‐year‐old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID‐19 vaccines.
format Online
Article
Text
id pubmed-10264932
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-102649322023-06-15 Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report Riazi, Ali Faghih Dinevari, Masood Abbasian, Samaneh Jabbaripour Sarmadian, Amirreza Clin Case Rep Case Report KEY CLINICAL MESSAGE: In patients with acute symptoms such as pain, swelling, and erythema of the upper extremities shortly after receiving COVID‐19 vaccines, even inactivated virus vaccines, these symptoms may indicate thrombosis, which may be due to the vaccination. ABSTRACT: BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine) is an inactivated whole virus vaccine to control the COVID‐19 pandemic. Studies concluded that inactivated COVID‐19 vaccines do not increase the risk of thrombosis. This report presents a 23‐year‐old man with the chief complaint of severe pain, swelling, and erythema of the right upper extremity following his second dose of the Sinopharm vaccine. Duplex ultrasound of the right upper extremity revealed upper extremity deep vein thrombosis, and treatment started with oral anticoagulation. It is probably the first upper extremity deep vein thrombosis case following inactivated COVID‐19 vaccines. John Wiley and Sons Inc. 2023-06-13 /pmc/articles/PMC10264932/ /pubmed/37323251 http://dx.doi.org/10.1002/ccr3.7535 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Riazi, Ali
Faghih Dinevari, Masood
Abbasian, Samaneh
Jabbaripour Sarmadian, Amirreza
Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title_full Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title_fullStr Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title_full_unstemmed Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title_short Upper extremity deep vein thrombosis following BBIBP‐CorV COVID‐19 vaccine (Sinopharm vaccine): A case report
title_sort upper extremity deep vein thrombosis following bbibp‐corv covid‐19 vaccine (sinopharm vaccine): a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264932/
https://www.ncbi.nlm.nih.gov/pubmed/37323251
http://dx.doi.org/10.1002/ccr3.7535
work_keys_str_mv AT riaziali upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport
AT faghihdinevarimasood upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport
AT abbasiansamaneh upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport
AT jabbaripoursarmadianamirreza upperextremitydeepveinthrombosisfollowingbbibpcorvcovid19vaccinesinopharmvaccineacasereport